ArticleChemSusChem2025
Core and End-Capped Engineering as a Powerful Tool in the Search of Long-Term High-Performance Dye-Sensitized Solar Cells.
Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In the search of new electroactive organic dyes in dye-sensitized solar cells technology, a series of D-π-A assemblies, named as TA-BTD-CNCOOH, OMeTA-BTD-CNCOOH, TA-Y6-CNCOOH, and OMeTA-Y6-CNCOOH is rationally designed and synthesized, in which precise modifications have been carried out in order to obtain structure-performance relations in the field of dye-sensitized solar cells. After careful evaluation of the photophysical and electrochemical properties of these semiconductors, these systems are applied as active materials, showing high performance with power conversion efficiency maximum values of 9.05% and 18.5% for outdoor and indoor conditions, respectively. In addition, the best material of these organic architectures, TA-BTD-CNCOOH, shows an excellent long-term stability, up to 3,360 h, with no significant variance in its performance over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.